MIFEPRISTONE
- Product NDC
- 83114-001
- 11-digit product format
- 831140001
- Labeler code
- 83114
- Product ID
- 83114-001_ed8c0b7a-2dac-2bb1-e053-2a95a90aa156
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- mifepristone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- PCI Pharma Services Canada, Inc.
- Application
- ANDA091178
- Marketing category
- ANDA
- Marketing start
- 2019-04-11
- Marketing end
- 0000-00-00
- Substance
- MIFEPRISTONE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Progestational Hormone Receptor Antagonists [MoA], Progestin Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 83114-001-01 | 83114000101 | 1 TABLET in 1 BLISTER PACK (83114-001-01) | 1 tablet | 2019-04-11 | 0000-00-00 | No | No | Current |
| 83114-001-06 | 83114000106 | 6 TABLET in 1 CARTON (83114-001-06) | 6 tablet | 2019-04-11 | 0000-00-00 | No | No | Current |